Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-006429
Filing Date
2022-02-10
Accepted
2022-02-10 16:15:38
Documents
45
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1221_citiuspharma.htm   iXBRL 10-Q 438083
2 CERTIFICATION f10q1221ex31-1_citiuspharma.htm EX-31.1 9104
3 CERTIFICATION f10q1221ex31-2_citiuspharma.htm EX-31.2 9182
4 CERTIFICATION f10q1221ex32-1_citiuspharma.htm EX-32.1 5459
  Complete submission text file 0001213900-22-006429.txt   2998337

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ctxr-20211231.xsd EX-101.SCH 41186
6 XBRL CALCULATION FILE ctxr-20211231_cal.xml EX-101.CAL 22774
7 XBRL DEFINITION FILE ctxr-20211231_def.xml EX-101.DEF 155876
8 XBRL LABEL FILE ctxr-20211231_lab.xml EX-101.LAB 333012
9 XBRL PRESENTATION FILE ctxr-20211231_pre.xml EX-101.PRE 166214
39 EXTRACTED XBRL INSTANCE DOCUMENT f10q1221_citiuspharma_htm.xml XML 296270
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 22614101
SIC: 2834 Pharmaceutical Preparations